Furthermore, silencing of the splicing factor SF3B1 or SRSF1 has been shown to induce splicing alteration of MCL1, which subsequently reduces Mcl-1L protein expression by chronic lymphocytic leukaemia cells [17–19]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.